Cite
MLA Citation
R. Sacco et al.. “OC.12.4 PROGNOSTIC FACTORS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) TREATED WITH LENVATINIB.” Digestive and liver disease, vol. 55, n.d., pp. S119–S120. http://access.bl.uk/ark:/81055/vdc_100181734711.0x000022